glp-1 adoption drugs are rewriting America's food preferences, says IFF Is a GLP-1 right for

Surgery is not right for everyone

The FDA notes it has collected reports of compounded GLP-1s not being refrigerated adequately or being made with poor-quality ingredients

First large study of GLP-1 receptor agonists during pregnancy

GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1 receptor agonists, including Ozempic, Semaglutide, and Rybelsus, have surged over the last five years as their effectiveness in promoting weight loss gains attention beyond type 2 diabetes care

Phase 2 trial dosing groups explained The trial randomized participants into seven groups

brief OTC support if clinician approves